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Thymic malignancies are relatively rare, but for the patientsand families that are affected, this is not an acceptable
excuse for the state of affairs, in which many clinicians
accept making decisions with very little knowledge, and the
rate of progress is slow. Clearly, we need to find effective
ways to combine information from across the world; this is
the goal of the International Thymic Malignancy Interest
Group (ITMIG). To collaborate, everyone must speak the
same language with respect to this disease. It is surprising
how many ambiguities exist and how much disparate inter-
pretations of the same terms preclude meaningful compari-
sons. To create the foundation for collaborative work, ITMIG
engaged the global thymic community to discuss and develop
a consensus regarding key definitions and policies. This issue
of the Journal of Thoracic Oncology contains the result of
this work.
The process followed by ITMIG has been to broadly
engage as many as possible to build a consensus that is
acceptable, representative, and consistent. Small groups were
assembled to develop initial proposals, which were revised in
discussion with extended workgroups (involving approxi-
mately 80 people). These workgroups were then brought
together for a 2-day working conference held at Yale Medical
School on November 15 and 16, 2010, where proposed
definitions and policies were further debated and brought in
alignment with one another. This was followed by circulation
to the entire ITMIG membership for further input. The
revised, final documents were approved by the ITMIG mem-
bership for adoption as the standard for all ITMIG projects
(Figure 1). It is hoped that these will be adopted as a standard
for all future work and publications on thymic malignancies,
whether done by ITMIG or independently.
Thymic tumors have several features that are unusual
compared with other malignancies in general. Besides the
relative low incidence, many tumors exhibit rather indolent
behavior. This has many implications affecting which out-
comes are most clinically relevant to assess. This is addressed
in the article on Standard Outcomes for Thymic Malignan-
cies. This article was the first to be produced by ITMIG and
has been published previously. It is included here as an exact
duplicate of the original publication to provide a comprehen-
sive set of articles in this special issue of Journal of Thoracic
Oncology.
Most of the articles in this issue address aspects of the
clinical care of patients, including imaging, acquisition and
interpretation of biopsies, and key aspects of surgical, radia-
tion, and chemotherapy treatment. Furthermore, of the mul-
tiple stage classification systems proposed, the one in widest
use is the Masaoka-Koga system. One article addresses am-
biguities within the system that have resulted in varying
interpretations, making it difficult to draw comparisons be-
tween studies.
Although the tumor stage is a major determinant of
prognosis, it is only one aspect. Prognosis is affected by the
treatment given, patient-specific factors (i.e., comorbidities),
tumor-related factors, and others, collectively known as prog-
nostic factors. A review of the published data on prognostic
factors in thymic malignancies is presented in this issue.
However, it is important to note that the science of how to
identify a truly valid prognostic factor has advanced consid-
erably during the study periods of these series. Future prog-
ress in the definition of valid prognostic factors requires a
more thorough understanding of these biostatistical aspects;
the article by Dr. Go¨nen provides insight into this.
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FIGURE 1. Rate of approval by International Thymic Malig-
nancy Interest Group members of the definition of terms
and policies papers for adoption to achieve consistency in
data collection and reporting of results.
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Missing from this issue is a discussion of morphologic
features of thymic tumors. Exploration of these issues was
beyond the scope of the November workshop. A 3-day
ITMIG pathology workshop in March 2011 represents a start
to address these issues.
Consistent definitions will promote two major ITMIG
projects: creation of a global collaborative database and a
joint project with the International Staging Committee of
the International Association for the Study of Lung Cancer
to develop a formal, validated thymic staging system for
the 8th edition of the American Joint Commission on
Cancer Staging Manual. However, consistent definitions
and policies will promote research on all fronts in thymic
malignancies. It must be emphasized that the definitions
and policies, although introducing consistency, are not
meant to be static; there is every expectation that future
research will continue to refine our practices and our
shared terminology. It is hoped that the articles published
in this issue will stimulate research challenging and refin-
ing the very tenets proposed in this issue. The opportuni-
ties afforded by the first steps presented here make further
progress much more likely and achievable. We hope that
the initial steps taken here will help to align and focus our
efforts and pave the way forward.
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